Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000601:surgery; D000328:Adult; D000450:Aldosterone / Q000652:urine; D000818:Animals; D001681:Biological Assay; D001806:Blood Urea Nitrogen; D002740:Chlorothiazide; D003404:Creatinine / Q000097:blood / Q000652:urine; D003937:Diagnosis, Differential; D004032:Diet; D005110:Extracellular Space; D005260:Female; D005665:Furosemide; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000188:drug therapy; D006973:Hypertension / Q000175:diagnosis*; D007008:Hypokalemia; D007606:Juxtaglomerular Apparatus / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D011187:Posture; D011188:Potassium / Q000097:blood / Q000652:urine; D051381:Rats; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use; D014642:Vanilmandelic Acid / Q000652:urine
D013148:Spironolactone; D000450:Aldosterone; D014642:Vanilmandelic Acid; D002740:Chlorothiazide; D005665:Furosemide; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium